Vaccines broader value advisory board
On the 11th of November Pfizer organized an advisory board on the broader value of vaccines. Experts of the field were invited to provide feedback on the broader benefits of vaccines and how to apply to HTA assessment to ensure full value of vaccines has been captured.
During the meeting, the different frameworks available and the usefulness of these frameworks for decision making were also discussed. Inge van der Putten was invited to give her expert opinion based on her findings on the PhD thesis: Using information on the broader economic impact of vaccines in evidence-informed decision making.
Also read
-
UM to play a more prominent role in Dutch scientific infrastructure
Eleven consortia from various scientific disciplines are set to launch projects of great value to science. The Dutch government is making a total of €197 million available for this purpose. Scientists from Maastricht University (UM) are closely involved in seven of the eleven projects.
-
17 million for Dutch mega cohort: working together to build healthier ageing
MUMC+ is main applicant in the NCC: a unique research infrastructure with data from almost half a million Dutch citizens.
-
Letting bone and cartilage repair themselves
Tim ten Brink focuses on developing implants for damaged bone and cartilage, so eventually there is less need for invasive surgery.
